Chief Executive Officer, Degron Therapeutics
Our CEO and Co-founder, Lily Zou, Founded Fosun Pharma USA Inc., a US subsidiary of Fosun Pharma. Created Fosun’s first US incubator, FUSION Bio ventures, to invest in cutting-edge technologies and build companies to enhance Fosun’s innovative R&D capabilities. On the specialty pharma side, built a team including BD, R&D, Regulatory Affairs, Sales, Marketing and Commercial Operations, and established Fosun’s first commercial infrastructure in the US. Launched 16 injectable products in the US and drove growth through in-licensing and acquisitions. as well as internal R&D and commercialization in the US. Won multiple Fosun Pharma awards.